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Tuberculosis in Hong Kong—patient
characteristics and treatment outcome
Objectives. To identify the general characteristics of patients with tuberculosis,
and to evaluate their treatment outcomes.
Design. Retrospective study.
Setting. Tuberculosis and Chest Service, Department of Health, Hong Kong.
Subjects and methods. All patients with tuberculosis registered for treatment
from 1 January 1996 to 31 December 1996 were included in the study. Infor-
mation was extracted from their medical records at treatment commencement
and at 12 and 24 months after treatment was instigated. Data gathered included
demographic data, past treatment, site of disease, case category, treatment regimen,
bacteriological status, and treatment outcome.
Results. There were 5757 patients for analysis. Approximately one third of
patients were aged 60 years or older, and 69.1% were male. Pulmonary disease
alone occurred in 77.7% of patients, while both pulmonary and extrapulmonary
diseases occurred in 8.6%. New patients comprised 84.6% of cases, and 16.3%
had concomitant illnesses. There was excess risk of disease among patients who
were male, elderly, or who had silicosis. Only 0.1% of patients were co-infected
with human immunodeficiency virus infection. Among the 5757 cases evaluated,
1324 (23.0%) were new patients with a positive sputum smear, 299 (5.2%) were
patients who were retreated with a positive sputum smear, and 4134 (71.8%)
were new or retreatment patients with a negative sputum smear. The overall
treatment completion rates at 12 and 24 months were 80.4% and 84.8%,
respectively. Males and patients aged 60 years or older had lower treatment
completion rates. Non-adherence, transfer to other services, and mortality among
the elderly were key factors influencing treatment outcomes. Co-morbidity was
associated with better case-holding, and this more than compensated for its
effect on prolongation of treatment and mortality.
Conclusions. There was an excess risk of tuberculosis among male and elderly
patients, who also had a less favourable outcome. Active screening of clearly
identified risk groups may be appropriate but requires the completion of more
in-depth studies and careful cost-effectiveness analyses. Further efforts with
respect to case-holding are indicated to address treatment defaulting and
transfer rates.
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Introduction
The notification rate for tuberculosis (TB) in Hong Kong
declined significantly between 1950 and 1990. In 1995, the
notification rate was at a low of 100.9/100 000. Since 1996,
however, there has been an increase in the notification rate—
117.3/100 000 in 1998 and 113.7/100 000 in 2000—and the
rate has since failed to decline.1
The exact reasons for the recent stagnant trend in the TB
notification rate in Hong Kong are not known. In many
countries, poor treatment and acquired HIV infection have
been found to be the major reasons for the resurgence of
TB.2 In view of such observations, the World Health Organ-
ization (WHO) has recommended that directly observed treat-
ment (DOT), short course (DOTS) is the treatment of choice
for TB.3 Hong Kong, however, was among one of the first
places to implement DOT in the 1970s,4 and this was the
probable reason for the dramatic decline in the rate of TB
from 1970 to the 1980s. The local prevalence of HIV infec-
tion has always been relatively low.5 While there has been
an improvement in notification of TB by physicians,6 it is
likely that other factors are also contributing to the current
elevated rates. This study was undertaken to examine the
reasons for the failure of the TB rate to decline. The aim was
to identify the general characteristics of patients with TB
seen by the Hong Kong Government Tuberculosis and Chest
Service (TB&CS), and to evaluate their treatment outcome.
Subjects and methods
All patients registered for treatment of TB with the TB&CS
(which treats approximately 80% to 90% of all notified TB
patients in Hong Kong) from 1 January 1996 to 31 Decem-
ber 1996 were included in the study. The year 1996 was
chosen because an increase in the TB notification rate was
first noted in that year, and population statistics were also
available through a census conducted during that year. In
addition, in 1996, a set of programme forms was introduced
for systematic data collection of all patients with TB
managed by the TB&CS. The programme forms recorded
the following information: name, date of treatment com-
mencement, age, sex, previous treatment, site of disease
(pulmonary or extrapulmonary), and other medical con-
ditions. The forms also recorded bacteriological status
before treatment, at 2 months, 6 months, and at the end of
treatment, and treatment outcome at intervals after treat-
ment commencement. Data were obtained for each patient
through the completion and submission of programme forms
by clinicians at the TB&CS at the start of treatment and at
12 and 24 months after the start of treatment. These data
were supplemented by a review of medical records for
patients with missing forms, missing information on forms,
or inconsistent information between completed forms, and
for all patients with extrapulmonary TB. The data were
entered into the Epi-Info database (Version 6; Centers for
Disease Control and Prevention, Atlanta, US) and checked
for accuracy by another person. The data were then exported
to the Statistical Package for the Social Sciences (Windows
version 6.0; SPSS Inc., Chicago, US) and edited before
analysis.
Analysis
Definitions used in the study are outlined in the Box. They
were modified slightly from those provided by the Inter-
national Union Against Tuberculosis and Lung Diseases.7
Statistical analyses were carried out using Statistical
Package for the Social Sciences (Windows version 6.0).
Continuous variables were compared using the Student’s
independent samples t test. Proportions were compared
using the Chi squared test. Differences were considered
significant at P<0.05.
Results
There were 5971 patients registered with the TB&CS for
treatment of TB in 1996. Of these, 103 had an incorrect
diagnosis, 106 had an atypical mycobacterial infection, and
five received chemoprophylaxis only. The number of valid
patients for the following analysis was thus 5757.
Patient characteristics
Patient characteristics are summarised in Table 1. This shows
that TB affected men more frequently than women (69.1%
versus 30.9%; P<0.01) in Hong Kong. Approximately one
third of patients were aged 60 years or older. The mean age
of male patients was significantly older than that of female
patients (50.6 years versus 43.5 years; P<0.01). The male
to female ratio was higher among those aged 60 years or
older than among those younger than 60 years (3.36:1
versus 1.85:1; P<0.01).
The majority of patients had pulmonary disease.
Pulmonary disease alone occurred in 77.7% of patients.
Extrapulmonary TB without lung involvement occurred in
13.7%, while both extrapulmonary and pulmonary diseases
occurred in 8.6% of patients. Extrapulmonary disease
tended to occur more commonly among women.
The majority of patients (84.6%) were new patients.
There were more men than women treated for relapsed
disease (15.1% versus 8.0%; P<0.01), and also more men
with a history of previously defaulting treatment (2.8%
versus 0.7%; P<0.01).
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Concomitant illnesses occurred in 16.3% of all patients,
and was significantly higher among men than women
(18.3% versus 11.9%; P<0.01), and also in those aged
60 years or older compared with those younger than
60 years (27.8% versus 10.3%; P<0.01). Diabetes, silicosis,
liver disease, and lung cancer were common concomitant
medical illnesses associated with TB.
Almost 10% of all patients with TB also had diabetes
at the time of diagnosis. Of the 555 patients with diabetes,
75.1% were male, and 57.6% were aged 60 years or older.
The mean age (standard deviation) for this group of patients
was 60.6 years (12.4 years). Only six (0.1%) patients had
documented HIV infection.
Treatment outcomes
Among the 5757 patients, 1324 (23.0%) were new patients
with a positive sputum smear, 299 (5.2%) were retreatment
patients with a positive sputum smear, and 4134 (71.8%)
were sputum smear-negative patients, including both new
and retreatment patients (Table 2).
At 12 months, 80.4% of patients had completed treat-
ment, 8% had defaulted, 3.6% had been transferred, 3.9%
had died, and 4.1% were still receiving treatment. However,
for retreatment patients with a positive sputum smear at
treatment commencement, only 71.6% completed treatment,
10.0% defaulted treatment, 2.3% were transferred, 6.0%
had died, and 10.0% were still receiving treatment. There
Box. Definitions used in the study
A patient with tuberculosis: patient with acid-fast bacilli visible on microscopic examination of sputum (smear-positive) or on culture if
smear was negative; or in the absence of positive bacteriology, those with clinical and radiological features compatible with tuberculosis
Pulmonary patients: patients with tuberculosis of the lungs, including those sputum smear-positive and those sputum smear-negative
(provided a minimum of three sputum examinations had been performed)
Extrapulmonary patients: all other patients, including those with tuberculous pleurisy and miliary tuberculosis
Disease categories
New patients: patients who had never received treatment of 1 month or more in duration
Retreatment patients: all patients other than new patients, including:
Relapse patients: patients who, having previously been treated, were declared cured prior to the current episode of active
tuberculosis as defined above
Treatment after defaulting: patients treated for active tuberculosis after having interrupted treatment for more than 2 months
Failure of previous treatment: patients for whom, after initial treatment for smear-positive sputum, pulmonary tuberculosis remained
or became positive at 5 months or later during the course of treatment
Others: all other patients who had previously received treatment
Treatment outcome
Treatment completed: patients who had taken the prescribed course of treatment irrespective of the sputum smear status at the
completion of treatment (combining cured and treatment completed categories of the International Union Against Tuberculosis and
Lung Diseases)
Transferred: patients who had been transferred to continue treatment at another centre, but the results of treatment were unknown
Died: patients who died for any reason during the course of their treatment or during 24 months’ follow-up
Defaulted: patients who had failed to collect medication for more than 2 consecutive months after the date of the last attendance
during the course of treatment. Patients whose medications were stopped by their doctor before the completion of treatment were also
regarded as defaulted
Table 1. Characteristics of patients with tuberculosis
Female, n=1778 Male, n=3979 Total, n=5757
No. (%) No. (%) No. (%)
Age-group* (years)
0-19 134 (7.5) 175 (4.4) 309 (5.4)
20-39 812 (45.7) 1130 (28.4) 1942 (33.7)
40-59 376 (21.1) 1143 (28.7) 1519 (26.4)
≥60 456 (25.6) 1531 (38.5) 1987 (34.5)
Mean age (SD) [years]* 43.5 (20.7) 50.6 (19.0 48.4 (19.8)
Type of case*
Pulmonary only 1214 (68.3) 3260 (81.9) 4474 (77.7)
Extrapulmonary only 410 (23.1) 380 (9.6) 790 (13.7)
Pulmonary and extrapulmonary 154 (8.7) 339 (8.5) 493 (8.6)
Case category*
New patients 1618 (91.0) 3254 (81.8) 4872 (84.6)
Relapse <5 years 58 (3.3) 133 (3.3) 191 (3.3)
Relapse ≥5 years 83 (4.7) 471 (11.8) 554 (9.6)
Treatment after default 13 (0.7) 112 (2.8) 125 (2.2)
Failure of previous treatment 3 (0.2) 3 (0.1) 6 (0.1)
Others       3 (0.2) 6 (0.2) 9 (0.2)
Co-morbid illness* 212 (11.9) 727 (18.3) 939 (16.3)
Diabetes* 138 (7.8) 417 (10.5) 555 (9.6)
Silicosis* 1 (0.1) 83 (2.1) 84 (1.5)
Liver disease* 12 (0.7) 83 (2.1) 95 (1.7)
Lung cancer* 4 (0.2) 58 (1.5) 62 (1.1)
Other cancers 9 (0.5) 23 (0.6) 32 (0.6)
HIV infection 1 (0.1) 5 (0.1) 6 (0.1)
* P<0.05 for differences between male and female by Chi squared test or Student’s t test
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were also significant differences in outcome between
men and women, between young and elderly patients, and
between those with and without co-morbidity. A total of
82.9% of female patients completed treatment compared
with 79.3% of male patients (P<0.05). A greater proportion
(82.7%) of patients younger than 60 years completed treat-
ment compared with 76.0% of those aged 60 years or older
(P<0.05). Mortality for those younger than 60 years was
only 1.0% in sharp contrast to 9.4% for those aged 60 years
or older (P<0.01). More patients with concomitant medical
conditions (83.3%) completed treatment compared with
those without such conditions (83.3% versus 80.0%;
P<0.05) [Table 3].
At 24 months, 84.8% of all patients had completed
treatment. However, only 81.3% of retreatment cases with
an initial positive sputum smear had completed treatment.
More female patients than male patients had completed
treatment (86.8% versus 83.8%; P<0.05), as had more
patients younger than 60 years (86.3% versus 81.9%;
P<0.05). The difference in number of patients with con-
comitant medical conditions who completed treatment
compared with those without such conditions was more
marked (92.4% versus 83.6%; P<0.001).
Of the 4880 patients who completed treatment, 76 had
a relapse of TB, and this was bacteriologically confirmed
Table 3.  Outcome of patients at 12 and 24 months according to presence of concomitant medical conditions
Concomitant medical conditions Overall
Absent Present No. (%)
No. (%) No. (%)
No. of patients 4998 759 5757
At 12 months*
Treatment completed 3996 (80.0) 632 (83.3) 4628 (80.4)
Still receiving treatment 171 (3.4) 67 (8.8) 238 (4.1)
Transferred 207 (4.1) 2 (0.3) 209 (3.6)
Died 190 (3.8) 32 (4.2) 222 (3.9)
Defaulted treatment 434 (8.7) 26 (3.4) 460 (8.0)
At 24 months†
Completed treatment 4179 (83.6) 701 (92.4) 4880 (84.8)
No relapse 3273 (65.5) 546 (71.9) 3819 (66.3)
Relapse
Bacteriological 45 (0.9) 5 (0.7) 50 (0.9)
Clinical 23 (0.5) 3 (0.4) 26 (0.5)
Lost to follow-up 796 (15.9) 117 (15.4) 913 (15.9)
Died 42 (0.8) 30 (4.0) 72 (1.3)
Treatment not completed
Died 189 (3.8) 30 (4.0) 219 (3.8)
Transferred 195 (3.9) 1 (0.1) 196 (3.4)
Defaulted, not found 367 (7.3) 24 (3.2) 391 (6.8)
Defaulted but retreated 58 (1.2) 1 (0.1) 59 (1.0)
Treatment stopped 10 (0.2) 2 (0.3) 12 (0.2)
* P<0.05 for difference in outcome at 12 months between the two groups by Chi squared test
† P<0.05 for difference in outcome at 24 months between the two groups by Chi squared test
Table 2. Outcome of patients at 12 and 24 months by pre-treatment smear status
New patient, Retreatment patient, New or retreatment patient, Overall
smear-positive smear-positive smear-negative No. (%)
No. (%) No. (%) No. (%)
No. of patients 1324 299 4134 5757
At 12 months*
Treatment completed 1065 (80.4) 214 (71.6) 3349 (81.0) 4628 (80.4)
Still receiving treatment 69 (5.2) 30 (10.0) 139 (3.4) 238 (4.1)
Transferred 43 (3.2) 7 (2.3) 159 (3.8) 209 (3.6)
Died 61 (4.6) 18 (6.0) 143 (3.5) 222 (3.9)
Defaulted treatment 86 (6.5) 30 (10.0) 344 (8.3) 460 (8.0)
At 24 months†
Completed treatment 1136 (85.8) 243 (81.3) 3501 (84.7) 4880 (84.8)
No relapse 895 (67.6) 187 (62.5) 2737 (66.2) 3819 (66.3)
Relapse
Bacteriological 16 (1.2) 4 (1.3) 30 (0.7) 50 (0.9)
Clinical 11 (0.8) 3 (1.0) 12 (0.3) 26 (0.5)
Lost to follow-up 196 (14.8) 45 (15.1) 672 (16.3) 913 (15.9)
Died 18 (1.4) 4 (1.3) 50 (1.2) 72 (1.3)
Treatment not completed
Died 60 (4.5) 20 (6.7) 139 (3.4) 219 (3.8)
Transferred 40 (3.0) 6 (2.0) 150 (3.6) 196 (3.4)
Defaulted, not found 71 (5.4) 20 (6.7) 300 (7.3) 391 (6.8)
Defaulted but retreated 16 (1.2) 9 (3.0) 34 (0.8) 59 (1.0)
Treatment stopped 1 (0.1) 1 (0.3) 10 (0.2) 12 (0.2)
* P<0.05 for difference in outcome at 12 months between all three groups by Chi squared test
† P<0.05 for difference in outcome at 24 months between all three groups by Chi squared test
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for 50 patients. Only 59 of the 450 patients who defaulted
treatment were found and retreated.
Discussion
According to the 1996 by-census, only 14.3% of the popu-
lation were aged 60 years or older8 while, as shown in
Table 1, 34.5% of the patients with TB were in this age-
group. There was clearly an excess of elderly patients with
TB seen at the TB&CS. The 1996 notification registry
figures indicate a generally increasing risk of TB with age
(Fig 1).1 While the overall notification rate was 101.0
patients per 100 000, the notification rate was as high as
361.4 patients for those aged 75 years or older. Accord-
ing to data from the Census and Statistics Department9 and
from the TB notification registry,1 there have been in-
creasing proportions of elderly citizens within the local
population, and an even more marked increase in the
proportion of elderly among TB patients during the past
few decades (Fig 2). In 1971, only 8.0% of patients with TB
were aged 65 years or older, with 1.7% aged 75 years or
older. The corresponding percentages had increased to
36.2% and 19.0 %, respectively, in 2001. Since the popu-
lation in Hong Kong is ageing, it is likely that elderly pa-
tients will account for an increasing proportion of the total
TB caseload. This may be one of the factors accounting for
the persistently high rate of TB reported in Hong Kong.
As reported in a previous paper on sex differences in
TB,10 men had a higher rate of TB than women in all age-
groups. The male to female ratio was higher among those
aged 60 years or older. Male patients aged 60 years or
older constituted 26.6% of the total patient pool in this
sample, a sizeable risk group.
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Although this study covered only 89% (5757/6501) of
all TB notifications, excluding patients managed outside
the TB&CS, it may serve to highlight other potential risk
factors for TB in Hong Kong residents. Silicosis is a well-
known risk factor for TB and there were 84 patients with
TB and silicosis in this study. If the number of surviving
patients with confirmed silicosis in Hong Kong was to be
approximately 3000,1 the annual risk of TB among people
with silicosis was approximately 2800/100 000. This figure
is much higher than the overall annual notification rate
of 101/100 000 in 1996. However, the absolute number of
patients with silico-TB was small, and these patients were
unlikely to have affected the overall trend in TB rates in
Hong Kong.
In this study, only six patients with TB were known to
be infected with HIV. Voluntary HIV testing was offered to
all patients with TB attending the TB&CS, and the uptake
rate was approximately 90%. The low incidence of HIV in-
fection in this study is supported by the results of unlinked
anonymous assays periodically carried out on samples from
patients attending the TB&CS. These have given the
incidence of HIV infection as approximately 0.13% to
0.70% between 1990 and 2000.1 Such low incidence reflects
the relatively low incidence of HIV infection in the general
population. Indeed, the HIV seropositive rate among blood
donors is only 5/100 000,5 and the incidence in the general
population is likely to be well below 0.1%. These results
suggest that while the risk for TB is high among patients
with HIV infection, HIV infection is unlikely to have con-
tributed to the stagnation in TB rates seen in Hong Kong
during the past decade.
Table 4 shows the estimated rate of TB among patients
with diabetes. Using the number of patients with TB identi-
fied with diabetes in this study and the population at risk
based on local statistics,1,8,11 the rate of TB for each age-
group was estimated. In 1996, 10% of all patients with
TB treated in the chest clinics had diabetes. The TB rates
among individuals with diabetes did not differ greatly from
those among the general population, with the exception of
men aged between 45 and 54 years. It should be stressed
that TB patients with diabetes managed outside the TB&CS
have not been included in this study. A higher prevalence of
diabetes could well be found among patients managed
solely inside hospitals, and thus the rate of TB among
patients with diabetes may have been underestimated.
At present, the overwhelming majority of patients with
TB in Hong Kong are identified through passive case finding,
that is, encouraging patients with symptoms suggestive of
TB to come forward for screening. An active screening
programme exists mostly for examination of contacts. The
finding of high-risk groups raises the question of whether
active screening for TB should be extended to these groups.
In a series of studies conducted between 1960 and 1973 in
different parts of the world, it was shown that, even in places
with active case-finding programmes, approximately 60%
of sputum smear-positive patients were discovered because
of their symptoms.12,13 Only 20% of new patients were found
through indiscriminate mass radiography alone.12 This is
explained by the relative rapidity with which the infection
develops, with symptoms developing more rapidly than
repeat screening can be accomplished.
In a survey completed by the TB&CS in 1981, the yield
of patients with active TB was 10% to 15% among new
clinic attendees,14 well over the likely yield among any of
the risk groups found in this study. Screening directed at
latent infection instead of active disease may potentially give
a higher yield.15 However, the existing screening and treat-
ment tools for latent TB infection are far from ideal. The
tuberculin test is confounded by previous bacille Calmette-
Guérin vaccination and atypical mycobacterial infection,
and only about 10% of immunocompetent patients with
latent TB infection ever develop the disease.16 Treatment
of latent TB often involves a long duration of treatment with
drugs that have potential for adverse events.17 These factors
seriously limit the widespread application of such an
approach. Therefore, passive case finding must remain one
of the cornerstones of the local TB control programme, as
in most other areas of the world.
Among household contacts, a regularly screened high-
risk group, the yield of active TB has been in the order of
1% to 2%,1,18 doubling to more than 3% at the extremes of
Table 4. Estimated risk of tuberculosis among patients with diabetes in Hong Kong
Age-groups No. in Hong Kong No. with tuberculosis Estimated No. of patients with No. of patients with
(years) population with and diabetes tuberculosis among diabetic tuberculosis in the general
diabetes in 199611 in this study  individuals in Hong Kong* population of Hong Kong
(per 100 000) (per 100 000)
Male
25-34 11 164 8 72 97
35-44 34 945 35 100 99
45-54 37 777 79 209 150
55-64 50 647 139 274 266
65-74 42 141 108 256 379
Female
25-34 8804 3 34 67
35-44 19 120 15 78 56
45-54 35 403 20 57 49
55-64 51 431 28 54 58
65-74 61 061 51 84 94
* Tuberculosis patients with diabetes treated outside the TB&CS have not been included
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age for both sexes.18 Among elderly people in nursing homes,
a high rate of TB, in the range of 1000 to 2000/100 000, has
been estimated by a previous study.19 Further studies and
cost-effectiveness analyses are needed to assess the role of
screening programmes among such well-defined risk groups.
Chaulk and Kazandjian20 reported the findings of the
Public Health Tuberculosis Guidelines Panel in 1998 on
treatment outcome in the US. The panel chose 27 studies
for review of treatment completion for pulmonary TB and,
among these, 18 had implemented DOT. They were classi-
fied into three categories. In the first category, the 12 stud-
ies based on comprehensive, patient-centred DOT strategies,
such as fully supervised DOT with multiple incentives and
enablers (enhanced DOT), reported the highest treatment
completion rates.21-32 The completion rates ranged from
86.0% to 96.5% for a variety of patient populations, includ-
ing alcoholics, patients with substance abuse problems,
incarcerated patients, homeless persons, and patients in-
fected with HIV. The rate of TB relapse reported in these
studies ranged from 0% to 11.5%. For the four studies of
DOT in the second category, without extensive enablers and
incentives, treatment completion rates ranged from 85.0%
to 87.6%, and reported rates of relapse ranged from 0.8% to
4.9%.33-36 For the two studies in the third category with modi-
fied DOT, supervision was used for only part of the treat-
ment period (typically during the hospitalisation phase of
therapy), and thereafter, patients were self-supervised.37,38
This strategy appeared to be less effective, with treatment
completion rates ranging from 78.6% to 82.6%. The first
two categories included two studies of DOT from Hong
Kong,31,36 evaluating the treatment programme in the 1970s
and 1980s.
In 1996, among patients attending the TB&CS, 80.6%
completed treatment at 12 months, but 84.8% completed
treatment by 24 months. Thus, the treatment completion
rate in Hong Kong at 12 months, although quite reasonable,
still fell somewhat short of the goal of the 85% treatment
success rate at 12 months for national tuberculosis pro-
grammes recommended by the WHO for all active cases.3
As shown in Table 2, the treatment default rate at 12 months
was 8.0%, accounting for 40.7% (460/1129) of all un-
favourable outcomes, while the transfer rate was 3.6%,
accounting for 18.5% (209/1129). As patients who default
treatment may remain a source of infection and also acquire
drug resistance, this group may have contributed in part to
the persistently high rate of TB in Hong Kong. The current
DOT programme employed by the Hong Kong TB&CS
uses a combination of incentives and enablers, including
education for patients and their families, intermittent
client-focused regimens, incentives such as money for extra
nutrition, referrals to other social services, as well as the
use of outreach teams and tracing of patients who default
treatment. Surveillance of Mycobacterium tuberculosis
drug resistance in Hong Kong during the period from 1986
to 1999 showed a significant decline in drug resistance.39
The overall resistance to one or more drugs was reduced
from approximately 17% to 12% for new patients and from
36% to 25% for retreatment patients, while the correspond-
ing figures for multidrug resistance were reduced from
2.7% to 1.0% and from 15.9% to 8.3%, respectively. Not-
withstanding the data presented, more in-depth studies are
required to examine factors that may affect case-holding in
Hong Kong among a relatively mobile population with free-
dom of choice in seeking medical treatment.
In this study, the mortality rate for all patients with TB at
12 months was 3.9%, accounting for approximately 20%
(222/1129) of the patients with unfavourable outcome. There
was also a sharp contrast in mortality rates between elderly
and younger patients. As more than one third of patients
were aged 60 years or older, the higher mortality rate may
have contributed to the overall low treatment completion rate.
The high prevalence of co-morbidity in this study is
consistent with the relatively high proportion of elderly
patients. As shown in Table 3, 8.8% of patients with co-
morbidity were receiving treatment at 12 months compared
with 3.4% of those without co-morbidity. This may reflect
the more frequent need to modify the treatment regimen,
either to decrease the risk of side-effects or as a result of
actual side-effects. Although 4.1% of patients were still
receiving treatment at 12 months, accounting for another
20% (238/1129) of patients with unfavourable outcomes at
12 months, most of these patients were eventually success-
fully treated as reflected by the better treatment completion
rate at 24 months. It is evident from Table 3 that the lower
treatment defaulting and transfer rates associated with co-
morbidity more than compensated for the effect of prolonged
treatment and higher mortality. Indeed, the treatment com-
pletion rates seen for those with concomitant medical
conditions were higher than those without co-morbidity at
both 12 months and 24 months.
Conclusion
This study found an excess of TB disease risk and a less
favourable treatment outcome for elderly, male patients in
Hong Kong. While consideration should be given to extend-
ing active screening programmes to such clearly identified
risk groups, further studies and careful cost-effectiveness
analyses are called for before implementation of such pro-
grammes is indicated on a service-wide scale. The treatment
success rate seen at 12 months was reasonably good, although
short of the WHO goal of 85%. More in-depth studies and
efforts with respect to case-holding should also be con-
sidered to address treatment default and transfer rates.
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